Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Baseline characteristics of CD patients (n = 108)

From: Association of vitamin D and platelet-to-lymphocyte ratio in treatment escalation risk for newly diagnosed Crohn’s disease adults

Variables

Non-Vitamin D Deficiency

Vitamin D Deficiency

P-value

(N = 23)

(N = 85)

Sex (n, %)

   

Female

15 (65.2%)

56 (65.9%)

1.000

Male

8 (34.8%)

29 (34.1%)

 

Age (years)

   

Mean (SD)

36.5 (15.5)

32.8 (12.4)

0.295

BMI (kg/m²)

   

< 18.5

12 (52.2%)

52 (61.2%)

0.468

18.5 ~ 23.9

10 (43.5%)

26 (30.6%)

 

24 ~ 27.9

1 (4.3%)

7 (8.2%)

 

Region (n, %)

   

Urban

11 (47.8%)

36 (42.4%)

0.816

Rural

12 (52.2%)

49 (57.6%)

 

Occupation (n, %)

   

Unemployeed

7 (30.4%)

20 (23.5%)

0.716

Employeed

13 (56.5%)

45 (52.9%)

 

Student

2 (8.7%)

12 (14.1%)

 

Retired

1 (4.3%)

8 (9.4%)

 

Smoking status (n, %)

   

Current smoker

2 (8.7%)

10 (11.8%)

0.907

Former smoker

2 (8.7%)

8 (9.4%)

 

Non-smoker

19 (82.6%)

67 (78.8%)

 

Season of Vitamin D measurement (n, %)

  

Spring

3 (13.0%)

20 (23.5%)

0.062

Summer

11 (47.8%)

18 (21.2%)

 

Fall

7 (30.4%)

29 (34.1%)

 

Winter

2 (8.7%)

18 (21.2%)

 

Disease behavior (n, %)

   

B1-inflammatory disease

4 (17.4%)

28 (32.9%)

0.107

B2-stricturing disease

12 (52.2%)

25 (29.4%)

 

B3-penetrating disease

7 (30.4%)

32 (37.6%)

 

Disease location (n, %)

   

L1—ileal location

7 (30.4%)

35 (41.2%)

0.686

L2—colon location

0 (0%)

1 (1.2%)

 

L3—ileocolon location

15 (65.2%)

44 (51.8%)

 

L4—including upper GI location

1 (4.3%)

5 (5.9%)

 

Disease activity (CDAI) (n, %)

   

Remission

1 (4.3%)

6 (7.1%)

0.329

Mild

3 (13.0%)

11 (12.9%)

 

Moderate

19 (82.6%)

58 (68.2%)

 

Severe

0 (0%)

10 (11.8%)

 

Extraintestinal manifestation (n, %)

   

No

18 (78.3%)

67 (78.8%)

1.000

Yes

5 (21.7%)

18 (21.2%)

 

History of perianal surgery (n, %)

   

No

17 (73.9%)

62 (72.9%)

1.000

Yes

6 (26.1%)

23 (27.1%)

 
  1. BMI, Body Mass Index; CDAI, Crohn’s Disease Activity Index